BR0017013A - Composições de antibiótico azalìdeo - Google Patents

Composições de antibiótico azalìdeo

Info

Publication number
BR0017013A
BR0017013A BR0017013-5A BR0017013A BR0017013A BR 0017013 A BR0017013 A BR 0017013A BR 0017013 A BR0017013 A BR 0017013A BR 0017013 A BR0017013 A BR 0017013A
Authority
BR
Brazil
Prior art keywords
antibiotic compositions
azaldehyde
compositions
antibiotic
solvents
Prior art date
Application number
BR0017013-5A
Other languages
English (en)
Other versions
BR0017013A2 (pt
BRPI0017013B1 (pt
Inventor
Wayne Alan Boettner
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22652702&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0017013(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of BR0017013A publication Critical patent/BR0017013A/pt
Publication of BR0017013A2 publication Critical patent/BR0017013A2/pt
Publication of BRPI0017013B1 publication Critical patent/BRPI0017013B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

"COMPOSIçõES DE ANTIBIóTICO AZALìDEO". São descritas composições antibióticas compreendendo uma mistura de equilíbrio de isómeros azalídeos, água e um ou mais ácidos, e métodos para a preparação de tais composições. As composições antibióticas podem ser vantajosamente estabilizadas por adição de um ou mais co-solventes miscíveis em água. Em uma modalidade preferida, o um ou mais co-solventes é propilenoglicol.
BRPI0017013-5A 2000-01-27 2000-11-30 Composição de antibiótico azalídeo e método para sua obtenção BRPI0017013B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17848100P 2000-01-27 2000-01-27
US60/178,481 2000-01-27
PCT/IB2000/001824 WO2001055158A1 (en) 2000-01-27 2000-11-30 Azalide antibiotic compositions

Publications (3)

Publication Number Publication Date
BR0017013A true BR0017013A (pt) 2002-10-22
BR0017013A2 BR0017013A2 (pt) 2010-07-13
BRPI0017013B1 BRPI0017013B1 (pt) 2015-07-14

Family

ID=22652702

Family Applications (2)

Application Number Title Priority Date Filing Date
BRPI0017013-5A BRPI0017013B1 (pt) 2000-01-27 2000-11-30 Composição de antibiótico azalídeo e método para sua obtenção
BRPI0017013A BRPI0017013B8 (pt) 2000-01-27 2000-11-30 composição de antibiótico azalídeo e método para sua obtenção

Family Applications After (1)

Application Number Title Priority Date Filing Date
BRPI0017013A BRPI0017013B8 (pt) 2000-01-27 2000-11-30 composição de antibiótico azalídeo e método para sua obtenção

Country Status (21)

Country Link
US (2) US6514945B1 (pt)
EP (1) EP1250343B1 (pt)
JP (2) JP3893059B2 (pt)
AR (2) AR030045A1 (pt)
AT (1) ATE243703T1 (pt)
AU (1) AU779748C (pt)
BR (2) BRPI0017013B1 (pt)
CA (1) CA2398485C (pt)
CO (1) CO5251404A1 (pt)
DE (1) DE60003586T2 (pt)
DK (1) DK1250343T3 (pt)
ES (1) ES2199884T3 (pt)
MX (1) MXPA02007305A (pt)
NZ (1) NZ518665A (pt)
PA (1) PA8509801A1 (pt)
PE (1) PE20011050A1 (pt)
PT (1) PT1250343E (pt)
TN (1) TNSN01017A1 (pt)
TW (2) TWI331527B (pt)
WO (1) WO2001055158A1 (pt)
ZA (1) ZA200205958B (pt)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003040782A (ja) * 2001-05-31 2003-02-13 Pfizer Prod Inc アザリド抗生物質組成物
AU2002317415A1 (en) * 2001-08-01 2003-02-17 Pfizer Products Inc. Azalide antibiotic compositions
AU2005286723A1 (en) 2004-09-23 2006-03-30 Schering-Plough Pty. Limited Control of parasites in animals by the use of novel trifluoromethanesulfonanilide oxime ether derivatives
DE602005017419D1 (de) * 2004-11-19 2009-12-10 Schering Plough Ltd Kontrolle von parasiten bei tieren mittels verwendung von parasitiziden 2-phenyl-3-(1h-pyrrol-2-yl) acrylonitril-derivaten
CA2609574A1 (en) * 2005-06-09 2006-12-21 Schering-Plough Ltd. Control of parasites in animals by n-[(phenyloxy)phenyl]-1,1,1-trifluoromethanesulfonamide and n-[(phenylsulfanyl)phenyl]-1,1,1-trifluoromethanesulfonamide derivatives
US8119667B2 (en) * 2005-12-29 2012-02-21 Schering-Plough Animal Health Corporation Carbonates of fenicol antibiotics
US20070238700A1 (en) * 2006-04-10 2007-10-11 Winzenberg Kevin N N-phenyl-1,1,1-trifluoromethanesulfonamide hydrazone derivative compounds and their usage in controlling parasites
US20080044455A1 (en) * 2006-08-21 2008-02-21 Chaim Welczer Tonsillitus Treatment
CN101605756A (zh) * 2006-12-13 2009-12-16 先灵-普劳有限公司 氟苯尼考及其类似物的水溶性前药
CA2672795A1 (en) * 2006-12-13 2008-06-26 Schering-Plough Ltd. Water-soluble prodrugs of chloramphenicol, thiamphenicol, and analogs thereof
TWI430995B (zh) 2007-06-26 2014-03-21 Du Pont 萘異唑啉無脊椎有害動物控制劑
ES2549731T3 (es) 2007-06-27 2015-11-02 E. I. Du Pont De Nemours And Company Método para el control de plagas en animales
US7795231B2 (en) * 2007-10-04 2010-09-14 Insite Vision Incorporated Concentrated aqueous azalide formulations
TWI401023B (zh) 2008-02-06 2013-07-11 Du Pont 中離子農藥
CN102131772B (zh) * 2008-07-30 2015-03-11 英特威国际有限公司 用作氟苯尼考的中间体的*唑啉-保护的氨基二醇化合物的制备方法
UA107804C2 (xx) 2009-08-05 2015-02-25 Du Pont Суміші мезоіонних пестицидів
AU2010279574A1 (en) 2009-08-05 2012-02-09 E. I. Du Pont De Nemours And Company Mesoionic pesticides
UA110924C2 (uk) 2009-08-05 2016-03-10 Е. І. Дю Пон Де Немур Енд Компані Мезоіонні пестициди
MX2012001646A (es) 2009-08-05 2012-03-21 Du Pont Pesticidas mesoionicos.
RS54677B1 (sr) 2010-05-27 2016-08-31 E. I. Du Pont De Nemours And Company Kristalni oblici 4-[5-[3-hloro-5-(trifluorometil)fenil]-4,5 -dihidro-5-(trifluorometil)-3-izoksazolil]-n-[2-okso-2-[(2,2,2-trifluoroetil)amino]etil]-1-naftalenkarboksamida
US20130102551A1 (en) 2010-07-01 2013-04-25 Andreas Hotte Antibiotic compositions
US9212201B2 (en) * 2010-07-23 2015-12-15 Acea Biotech, Inc. Antifungal and antiparasitic polyene macrolides
WO2012087630A1 (en) 2010-12-20 2012-06-28 E.I. Du Pont De Nemours And Company Pyridine and pyrimidine compounds for controlling invertebrate
CN103619818A (zh) 2011-06-20 2014-03-05 纳幕尔杜邦公司 用于治疗蠕虫感染的杂环化合物
EP2736915A1 (en) 2011-07-27 2014-06-04 Farma GRS, d.o.o. New crystalline forms of tulathromycin
BR112014007819B1 (pt) 2011-11-11 2021-03-02 Exxonmobil Upstream Research Company método para produzir hidrocarbonetos
BR112014007821B1 (pt) 2011-11-11 2021-12-07 Exxonmobil Upstream Research Company Método para determinar a localização, tamanho, e composição fluida de um acúmulo de hidrocarboneto abaixo da superfície
TW201326128A (zh) 2011-11-28 2013-07-01 Du Pont 磺醯胺驅蟲劑
WO2013158422A1 (en) 2012-04-17 2013-10-24 E. I. Du Pont De Nemours And Company Heterocyclic compounds for controlling invertebrate pests
WO2014099837A1 (en) 2012-12-18 2014-06-26 E. I. Du Pont De Nemours And Company Sulfonamide anthelmintics
US9044508B2 (en) * 2013-03-15 2015-06-02 Insite Vision Corporation Concentrated aqueous azalide formulations
JP6437523B2 (ja) 2013-04-04 2018-12-12 プレジデント アンド フェローズ オブ ハーバード カレッジ マクロライドならびにそれらの調製および使用の方法
CN103588833B (zh) * 2013-10-30 2016-08-17 北京科技大学 动物抗菌素泰拉霉素的制备方法
RU2634793C1 (ru) 2014-03-07 2017-11-03 Эксонмобил Апстрим Рисерч Компани Способ разведки и система для обнаружения углеводородов по водяному столбу
CN104119413B (zh) * 2014-07-29 2016-08-24 华中农业大学 一种土拉霉素残留标示物的合成方法
CN106998685A (zh) 2014-10-08 2017-08-01 哈佛大学的校长及成员们 14‑元酮内酯及其制备和使用方法
EP3273969A4 (en) 2015-03-25 2018-11-21 President and Fellows of Harvard College Macrolides with modified desosamine sugars and uses thereof
WO2017124222A1 (zh) * 2016-01-18 2017-07-27 浙江海正药业股份有限公司 一种泰拉霉素的制备方法及其中间体
MX2021005421A (es) * 2018-11-19 2021-09-21 Zikani Therapeutics Inc Macrólidos de 13 miembros con sustitución cíclica en c10 y usos de los mismos.
TWI830987B (zh) 2020-03-12 2024-02-01 美商碩騰服務公司 免疫調節脲氮雜內酯
KR102589130B1 (ko) * 2021-03-24 2023-10-13 삼진제약주식회사 N-옥소 피리딘 화합물 발생을 억제하는 안질환 예방 또는 치료용 점안 조성물
MX2024002892A (es) 2021-09-07 2024-04-05 Zoetis Services Llc Azalidos inmunomoduladores.
EP4289268A1 (en) * 2022-06-07 2023-12-13 The Procter & Gamble Company Antimicrobial composition

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN1998000086A (es) * 1997-06-11 1999-03-08 Pfizer Prod Inc Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
HN1998000074A (es) * 1997-06-11 1999-01-08 Pfizer Prod Inc Derivados de macrolidos c-4 sustituidos
US6128174A (en) 1997-08-29 2000-10-03 Stereotaxis, Inc. Method and apparatus for rapidly changing a magnetic field produced by electromagnets
ES2281136T3 (es) * 1997-09-10 2007-09-16 Merial Ltd. Uso de 9a-azalidos como agentes antimicrobiales veterinarios.
DE60038610T2 (de) * 1999-05-18 2009-06-25 Pfizer Products Inc., Groton Neue kristalline formen eines makrolidantibiotikums

Also Published As

Publication number Publication date
PT1250343E (pt) 2003-11-28
US6514945B1 (en) 2003-02-04
DE60003586D1 (de) 2003-07-31
US20030013860A1 (en) 2003-01-16
CA2398485A1 (en) 2001-08-02
JP3893059B2 (ja) 2007-03-14
DE60003586T2 (de) 2004-01-08
TWI318880B (en) 2010-01-01
PA8509801A1 (es) 2002-02-21
MXPA02007305A (es) 2002-11-29
ATE243703T1 (de) 2003-07-15
TNSN01017A1 (fr) 2005-11-10
BR0017013A2 (pt) 2010-07-13
WO2001055158A1 (en) 2001-08-02
DK1250343T3 (da) 2003-09-22
EP1250343A1 (en) 2002-10-23
AR030045A1 (es) 2003-08-13
AR039387A2 (es) 2005-02-16
NZ518665A (en) 2005-02-25
BRPI0017013B1 (pt) 2015-07-14
AU779748C (en) 2005-12-08
AU1722801A (en) 2001-08-07
JP2006282676A (ja) 2006-10-19
CA2398485C (en) 2008-01-29
ES2199884T3 (es) 2004-03-01
EP1250343B1 (en) 2003-06-25
CO5251404A1 (es) 2003-02-28
TW201006476A (en) 2010-02-16
BRPI0017013B8 (pt) 2022-11-16
PE20011050A1 (es) 2001-10-19
JP2004500384A (ja) 2004-01-08
US20030073825A1 (en) 2003-04-17
TWI331527B (en) 2010-10-11
ZA200205958B (en) 2003-09-29
US6667393B2 (en) 2003-12-23
AU779748B2 (en) 2005-02-10

Similar Documents

Publication Publication Date Title
BR0017013A (pt) Composições de antibiótico azalìdeo
BR0211390A (pt) Tratamento de infecções da unha com no
BR0213207A (pt) remodelagem e glicoconjugação de peptìdeos
ECSP003682A (es) Compuestos para el tratamiento de la isquemia
NO20003233D0 (no) 4-hydrokykinolin-3-karboksamider og hydraziner som antivirale midler
ZA200007222B (en) Glycopeptide derivatives and pharmaceutical compositions containing the same.
BR9911869A (pt) Inibidores da transferase da proteìna farnesil para o tratamento das artropatias
AP9901478A0 (en) Compounds for the treatment of ischemia.
GB2380675A (en) Method of increased bioavailability of nutrients and pharmaceutical preparations with tetrahydropiperine and its analogues and derivatives
AR024138A1 (es) Inhibidores de la proliferacion celular
AR023529A1 (es) Una composicion champu acondicionadora del cabello y un metodo para acondicionar el cabello
NO20021859D0 (no) Nye digosakkarider, deres fremstilling samt farmasöytiske preparater
BR0001399A (pt) Processo para melhoria de estabilidade de viscosidade de uma composição aquosa, e composição
EA200000826A1 (ru) Галоидированные производные амидиноаминокислот, применимые в качестве ингибиторов no-синтазы
ECSP034531A (es) Derivados sustituidos de c-ciclohexilmetilamina
SV1999000204A (es) Derivados de indol ref. pcs10311aksr/bb
ECSP034530A (es) Derivados de 6-metil-tramadol sustituido en o
BR0109946A (pt) Derivados de eritromicina substituìda em 6-o tendo tolerância gastrointestinal
WO2003011266A3 (en) Azalide antibiotic compositions
ATE133645T1 (de) Inhibierte 141b
DK1073447T3 (da) N1-modificerede glycopeptider
DE60008378D1 (de) Ledergerben
UY26498A1 (es) Pirroles sustituidos
ATE227122T1 (de) Stabilisierte tablettenformulierung
ES2175661T3 (es) Derivados de la isoflavona, procedimientos para la preparacion de los mismos y composiciones farmaceuticas que los contienen.

Legal Events

Date Code Title Description
B03G Publication of an application: publication cancelled [chapter 3.7 patent gazette]

Free format text: REFERENTE A RPI 1659 DE 22/10/2002.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B25A Requested transfer of rights approved

Owner name: PAH USA 15 LLC (US)

B25D Requested change of name of applicant approved

Owner name: ZOETIS P LLC (US)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 14/07/2015, OBSERVADAS AS CONDICOES LEGAIS.

B25A Requested transfer of rights approved
B25G Requested change of headquarter approved
B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 30/11/2000 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 30/11/2020

B22E Other requirements [chapter 22.5 patent gazette]

Free format text: FORMULADA EXIGENCIA PARA ADEQUACAO OU CUMPRIMENTO DE DISPOSICOES LEGAIS NO PRAZO DE 60 (SESSENTA) DIAS DESTA DATA.

B16B Notification of grant cancelled [chapter 16.2 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 16.3 NA RPI NO 2629 DE 25/05/2021 POR TER SIDO INDEVIDA.

B21I Extinguishment of a patent or of a certificate of addition of invention: publication cancelled

Free format text: ANULADA A PUBLICACAO CODIGO 21.1 NA RPI NO 2630 DE 01/06/2021 POR TER SIDO INDEVIDA.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: RETIFICACAO REF. RPI 2323, DE 14/07/2015. PRAZO DE VALIDADE: 10 ANOS CONTADOS A PARTIR DE 14/07/2015, OBSERVADAS AS CONDICOES LEGAIS, PARA MATERIA RELATIVA A PRODUTOS E PROCESSOS COM APLICACAO VETERINARIA. PATENTE CONCEDIDA CONFORME A ADI 5.529/DF, COM APOSTILAMENTO DO PRAZO DE VALIDADE DA PROTECAO DA MATERIA RELATIVA A PRODUTOS E PROCESSOS FARMACEUTICOS E EQUIPAMENTOS E/OU MATERIAIS DE USO EM SAUDE, PARA APLICACAO EM HUMANOS.

B22O Other matters related to patents and certificates of addition of invention: legal action concerning patent

Free format text: INPI NO 52402.011451/2022-67 ORIGEM: 25A VARA FEDERAL DO RIO DE JANEIRO PROCESSO NO: 5071020-25.2022.4.02.5101/RJ SUBJUDICE COM PEDIDO DE ANTECIPACAO DE TUTELA AUTOR: OURO FINO SAUDE ANIMAL LTDA REU(S): ZOETIS SERVICES LLC E INPI-INSTITUTO NACIONAL DA PROPRIEDADE INDUSTRIAL

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: RETIFICACAO REF. RPI 2323, DE 14/07/2015. PRAZO DE VALIDADE: 10 ANOS CONTADOS A PARTIR DE 14/07/2015, OBSERVADAS AS CONDICOES LEGAIS, PARA MATERIA RELATIVA A PRODUTOS E PROCESSOS COM APLICACAO VETERINARIA. PATENTE CONCEDIDA CONFORME A ADI 5.529/DF, COM APOSTILAMENTO DO PRAZO DE VALIDADE DA PROTECAO DA MATERIA RELATIVA A PRODUTOS E PROCESSOS FARMACEUTICOS E EQUIPAMENTOS E/OU MATERIAIS DE USO EM SAUDE, PARA APLICACAO EM HUMANOS.